Sean Cullen
About Sean Cullen
Sean Cullen serves as the Vice President of Manufacturing at Inozyme Pharma, a position he has held since 2017. He has extensive experience in the biotechnology sector, having previously held senior roles at Geron Corporation, Wyeth Biotech, Ultragenyx Pharmaceutical Inc., and Layton BioScience.
Current Role at Inozyme Pharma
Sean Cullen serves as the Vice President of Manufacturing at Inozyme Pharma, a position he has held since 2017. In this role, he oversees the manufacturing processes and ensures the efficient production of biopharmaceuticals. His leadership contributes to the company's commitment to developing innovative therapies for patients with rare diseases. Inozyme Pharma is located in Boston, MA.
Previous Experience at Ultragenyx Pharmaceutical Inc.
Before joining Inozyme Pharma, Sean Cullen worked at Ultragenyx Pharmaceutical Inc. as Director/Senior Director of CMC Manufacturing from 2012 to 2017. His responsibilities included managing the chemistry, manufacturing, and controls processes, which are critical for the development of biopharmaceutical products. This role involved ensuring compliance with regulatory standards and optimizing manufacturing operations.
Career at Geron Corporation
Sean Cullen was employed at Geron Corporation from 2006 to 2012 as Senior Director of Manufacturing Operations. During his six-year tenure, he played a key role in overseeing manufacturing processes and operations, contributing to the company’s focus on developing innovative therapies. His experience at Geron laid a foundation for his subsequent roles in the biopharmaceutical industry.
Experience at Wyeth Biotech
From 2002 to 2006, Sean Cullen worked at Wyeth Biotech as Pilot Lab Operations Manager. In this position, he managed pilot-scale manufacturing operations, which are essential for transitioning from research to full-scale production. His work at Wyeth Biotech provided him with valuable insights into the biopharmaceutical manufacturing process.
Early Career at Layton BioScience
Sean Cullen began his career at Layton BioScience, where he served as Director of Manufacturing from 1997 to 2002. In this role, he was responsible for overseeing manufacturing operations, which included managing production schedules and ensuring product quality. This early experience contributed to his extensive knowledge of the manufacturing sector within the biopharmaceutical industry.